Pharmacoeconomic Analysis of Antithrombotic Treatment In Coronary Artery Disease (Cad) Patients With Clopidogrel Hypersensitivity After Percutaneous Coronary Intervention (Pci) von Cegec, I, Simic, I, Erdeljic Turk, V, Makar Ausperger, K, Aumiler Radacic, M, Kraljickovic, I, Juricic Nahal, D, Likic, R

Volltext

Outlook For Biosimilar Molecules Entering Croatian Pharmaceutical Market In The Period From 2016 To 2020 von Likic, R, Simic, I, Erdeljic Turk, V, Makar-Ausperger, K, Radacic-Aumiler, M, Cegec, I, Juricic Nahal, D, Kraljickovic, I

Volltext

Pregnancy Exposure to Drugs: Role of Clinical Pharmacologist von Radacic Aumiler, M, Erdeljic Turk, V, Makar-Ausperger, K, Likic, R, Bielen, L, Simic, I

Volltext

Clinically Guided Warfarin Dose Versus Genotyping In Early Achievement Of Stable Anticoagulant Effect Of Warfarin von Makar-Ausperger, K, Bozina, N, Erdeljic Turk, V, Likic, R, Radacic Aumiler, M, Ganoci, L, Francetic, I

Volltext

New drugs for bad bugs: what’s new and what’s in the pipeline? von Turk, V. Erdeljic, Simic, I, Likic, R, Makar-Ausperger, K, Radacic-Aumiler, M, Cegec, I, Juricic Nahal, D, Kraljickovic, I

Volltext

Pharmacoeconomic analysis comparing Clopidogrel Desensitization Protocol versus ticagrelor for Antithrombotic treatment in Coronary Artery Disease Patients with Clopidogrel Hyperse... von Cegec, I, Francetic, I, Erdeljic Turk, V, Makar Ausperger, K, Aumiler Radacic, M, Kraljickovic, I, Cacic, I, Likic, R

Volltext

Clinical pharmacology consultation and outcomes associated with pregnancy exposure to FDA X Drugs von Erdeljic Turk, V, Francetic, I, Makar Ausperger, K, Likic, R, Radacic-Aumiler, M

Volltext

P2.4 - Pharmacoeconomic Analysis of Antithrombotic Treatment In Coronary Artery Disease (Cad) Patients With Clopidogrel Hypersensitivity After Percutaneous Coronary Intervention (P... von Cegec, I., Simic, I., Erdeljic Turk, V., Makar Ausperger, K., Aumiler Radacic, M., Kraljickovic, I., Juricic Nahal, D., Likic, R.

Volltext

2.8 - New drugs for bad bugs: what’s new and what’s in the pipeline? von Turk, V. Erdeljic, Simic, I., Likic, R., Makar-Ausperger, K., Radacic-Aumiler, M., Cegec, I., Juricic Nahal, D., Kraljickovic, I.

Volltext

3.10 - Outlook For Biosimilar Molecules Entering Croatian Pharmaceutical Market In The Period From 2016 To 2020 von Likic, R., Simic, I., Erdeljic Turk, V., Makar-Ausperger, K., Radacic-Aumiler, M, Cegec, I., Juricic Nahal, D., Kraljickovic, I.

Volltext

Inadequate use of preventive strategies in patients receiving NSAIDs von Francetic, I, Bilusic, M, Macolic-Sarinic, V, Huic, M, Mercep, I, Makar-Ausperger, K, Erdeljic, V, Mimica, S, Baotic, I, Simic, P

Volltext

IS REFERRING PATIENTS WITH A POSITIVE HISTORY OF ALLERGIC DRUG REACTIONS OR ATOPY FOR ALLERGY TESTING TO LOCAL ANESTHETICS JUSTIFIED? von ERDELJIC, Viktorija, FRANCETIC, Igor, LIKIC, Robert, BAKRAN, Ivan, MAKAR-AUSPERGER, Ksenija, SIMIC, Petra

Volltext